Inactive Instrument

BioNexus Gene Lab Corporation Stock Other OTC

Equities

BGLC

US0906281086

Healthcare Facilities & Services

Sales 2022 10.93M Sales 2023 9.77M Capitalization 9.36M
Net income 2022 - Net income 2023 -2M EV / Sales 2022 14.9 x
Net cash position 2022 2.06M Net cash position 2023 5.78M EV / Sales 2023 0.37 x
P/E ratio 2022
-461 x
P/E ratio 2023
-3.2 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 35.63%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 40 23-07-31
Members of the board TitleAgeSince
Director/Board Member 68 22-03-06
Director/Board Member 48 Dec. 10
Chief Executive Officer 40 23-07-31
More insiders
BioNexus Gene Lab Corp., through its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd., focuses on the wholesale of chemical raw material products. The Company is engaged in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. The Company is also engaged in the business of developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. Its non-invasive blood screening tests analyze changes in ribonucleic acid (RNA) to detect the risk potentiality of approximately 11 different diseases. It offers a range of fiberglass reinforced plastic (FRP) products, which include Polyester Resin SHCP 268, Polyester Resin 9509 and Polyester Resin 2802. The FRP and other raw materials it offers are used to produce a variety of goods, including handrails, bench tops, cleanroom panels, and covers for various instruments used in manufacturing.
More about the company